Tobramycin Inhalant
Product Images NDC 42571-408

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 42571-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tobramycin-crtn.jpg (Tobramycin Crtn)

Tobramycin-crtn.jpg (Tobramycin Crtn)
Packaging label for Tobramycin Inhalation Solution, USP 300 mg/5 mL ampules by Micro Labs Limited. The label indicates 56 single-dose 5 mL ampules (28-day supply) in 14 pouches, with 4 ampules per pouch. The solution is for inhalation only by nebulizer and contains no preservatives. Storage instructions specify refrigeration.*
FDA Label Image

Tobramycin-fig-1.jpg (Tobramycin Fig 1)

Tobramycin-fig-1.jpg (Tobramycin Fig 1)
A line graph labeled 'Figure 1: Relative Change From Baseline in FEV1 % Predicted' depicting average relative changes over 24 weeks. It compares Tobramycin inhalation solution (Study 1 and Study 2) versus placebo in corresponding studies, showing data points with lines representing the four groups over time.*
FDA Label Image

Tobramycin-fig-2.jpg (Tobramycin Fig 2)

Tobramycin-fig-2.jpg (Tobramycin Fig 2)
A line graph titled 'Absolute Change From Baseline in Log10 CFUs' showing average change in Log10 CFUs on the y-axis versus weeks on the x-axis. The graph compares two studies with placebo and Tobramycin inhalation solution treatments over 24 weeks, indicating periods labeled 'on drug.'*
FDA Label Image

Tobramycin-figure-a.jpg (Tobramycin Figure A)

Tobramycin-figure-a.jpg (Tobramycin Figure A)
An instructional diagram showing components of a nebulizer set for inhalation therapy. Labeled parts include an air compressor, nebulizer cup, inspiratory valve cap, ampule containing medication, mouthpiece, clean paper or cloth towels, and tubing.*
FDA Label Image

Tobramycin-figure-b.jpg (Tobramycin Figure B)

Tobramycin-figure-b.jpg (Tobramycin Figure B)
An instructional illustration showing a pair of hands holding a blister pack containing five ampoules. One ampoule is being removed, indicating the process of taking out a single dose for use. This image relates to Tobramycin inhalant solution packaging or administration.*
FDA Label Image

Tobramycin-figure-c.jpg (Tobramycin Figure C)

Tobramycin-figure-c.jpg (Tobramycin Figure C)
An instructional illustration of a Tobramycin inhalant solution ampule showing the labeling area where the lot number and expiration date are indicated, including an arrow pointing to the expiration date location on the ampule.*
FDA Label Image

Tobramycin-figure-d.jpg (Tobramycin Figure D)

Tobramycin-figure-d.jpg (Tobramycin Figure D)
An instructional line drawing illustrating the assembly of a nebulizer device for inhalation therapy. The labeled components include the nebulizer top being placed onto the nebulizer cup, the mouthpiece, tubing, and the inspiratory valve cap. The image highlights the correct positioning and connection of these parts.*
FDA Label Image

Tobramycin-figure-e.jpg (Tobramycin Figure E)

Tobramycin-figure-e.jpg (Tobramycin Figure E)
An instructional diagram illustrating the assembly of a nebulizer cup and nebulizer insert for inhalant medication use. The image shows hands positioning the nebulizer insert into the nebulizer cup, indicating the top direction and rotational placement method.*
FDA Label Image

Tobramycin-figure-f.jpg (Tobramycin Figure F)

Tobramycin-figure-f.jpg (Tobramycin Figure F)
An instructional illustration showing parts of a nebulizer for inhalant use, including a nebulizer cup and a top piece placed on clean paper or cloth towels. The image highlights assembly or preparation steps for Tobramycin inhalant administration.*
FDA Label Image

Tobramycin-figure-g.jpg (Tobramycin Figure G)

Tobramycin-figure-g.jpg (Tobramycin Figure G)
An instructional illustration showing a hand adjusting or opening a device labeled 'Pulmo-Aide,' which is a respiratory therapy system commonly used for inhalant medications like Tobramycin solution.*
FDA Label Image

Tobramycin-figure-h.jpg (Tobramycin Figure H)

Tobramycin-figure-h.jpg (Tobramycin Figure H)
An instructional line drawing showing a hand unplugging a two-prong electrical plug from a wall outlet. The image includes an arrow indicating the direction of pulling the plug out from the socket.*
FDA Label Image

Tobramycin-figure-i.jpg (Tobramycin Figure I)

Tobramycin-figure-i.jpg (Tobramycin Figure I)
An instructional diagram showing hands opening or preparing a small inhalant vial, illustrating the twisting motion required to remove the cap. The image is likely related to the use of Tobramycin inhalant solution packaging or administration preparation.*
FDA Label Image

Tobramycin-figure-j.jpg (Tobramycin Figure J)

Tobramycin-figure-j.jpg (Tobramycin Figure J)
An illustration showing a hand holding a vial and dripping liquid into the top opening of a nebulizer device. The nebulizer has a mouthpiece extending horizontally, used for inhalation of the solution.*
FDA Label Image

Tobramycin-figure-k.jpg (Tobramycin Figure K)

Tobramycin-figure-k.jpg (Tobramycin Figure K)
An instructional illustration showing parts of a nebulizer assembly for inhalation use. It labels the nebulizer top with a semi-circle and stem, the nebulizer outlet, and the nebulizer cup. The diagram includes an arrow indicating the nebulizer top being placed onto the nebulizer cup.*
FDA Label Image

Tobramycin-figure-l.jpg (Tobramycin Figure L)

Tobramycin-figure-l.jpg (Tobramycin Figure L)
An instructional illustration showing assembly of a nebulizer for inhalation therapy. The image labels the mouthpiece and nebulizer cup, with an arrow indicating how the mouthpiece attaches to the nebulizer outlet on the cup.*
FDA Label Image

Tobramycin-figure-m.jpg (Tobramycin Figure M)

Tobramycin-figure-m.jpg (Tobramycin Figure M)
Illustration showing a respiratory inhalation device with a detachable inspiratory valve cap positioned above the device, indicating assembly instructions for the Tobramycin inhalant solution.*
FDA Label Image

Tobramycin-figure-n.jpg (Tobramycin Figure N)

Tobramycin-figure-n.jpg (Tobramycin Figure N)
An instructional diagram showing an inhaler device for Tobramycin solution inhalant. It highlights the air intake area on the device's body and illustrates how to attach an accessory piece to the bottom of the inhaler, indicating airflow direction with arrows.*
FDA Label Image

Tobramycin-figure-o.jpg (Tobramycin Figure O)

Tobramycin-figure-o.jpg (Tobramycin Figure O)
An instructional line drawing showing a hand pressing a switch or button on a device labeled "Pulmo-Aide." The image demonstrates operation or use of the Pulmo-Aide device, which is commonly used as a compressor or nebulizer in inhalation therapies.*
FDA Label Image

Tobramycin-figure-p.jpg (Tobramycin Figure P)

Tobramycin-figure-p.jpg (Tobramycin Figure P)
An instructional illustration showing a nebulizer device used for inhalant administration. The device consists of a main chamber with a mouthpiece from which vapor or mist is emitted, indicated by gray cloud-like shapes. Tubing extends from the bottom of the chamber for connection to a compressed air source.*
FDA Label Image

Tobramycin-figure-q.jpg (Tobramycin Figure Q)

Tobramycin-figure-q.jpg (Tobramycin Figure Q)
An instructional illustration showing a person using a respiratory inhalation device for Tobramycin solution. The image highlights the use of a nose clip while inhaling through the mouthpiece of the nebulizer device.*
FDA Label Image

Tobramycin-lbl1.jpg (Tobramycin Lbl1)

Tobramycin-lbl1.jpg (Tobramycin Lbl1)
Label for Tobramycin Inhalation Solution USP, 300 mg per 5 mL ampule. This is a 5 mL single-dose ampule for inhalation use by nebulizer. The label notes the product contains no preservatives and should be stored in a refrigerator. Manufactured for Micro Labs USA, Inc., with the labeler identified as Micro Labs Limited.*
FDA Label Image

Tobramycin-pouch.jpg (Tobramycin Pouch)

Tobramycin-pouch.jpg (Tobramycin Pouch)
Tobramycin Inhalation Solution USP 300 mg/5 mL ampules packaging label displaying product usage for inhalation by nebulizer. The label indicates four single-dose 5 mL ampules per pouch, no preservatives, and storage instructions recommending refrigeration at 2° to 8°C. Manufactured by Micro Labs Limited, India, and for Micro Labs USA, Inc.*
FDA Label Image

Tobramycin-structure.jpg (Tobramycin Structure)

Tobramycin-structure.jpg (Tobramycin Structure)
Chemical structure of tobramycin, shown as a molecular diagram illustrating the arrangement of atoms and bonds characteristic of this aminoglycoside antibiotic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.